Xenon Pharmaceuticals Inc.
XENE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$234,330 | -$182,393 | -$125,373 | -$78,882 |
| Dep. & Amort. | $2,560 | $3,541 | $1,624 | $906 |
| Deferred Tax | -$8,864 | -$292 | -$44 | $58 |
| Stock-Based Comp. | $50,717 | $32,372 | $20,376 | $10,017 |
| Change in WC | $5,713 | $5,635 | -$676 | -$2,647 |
| Other Non-Cash | $2,815 | -$4,190 | $5,663 | $1,046 |
| Operating Cash Flow | -$181,389 | -$145,327 | -$98,430 | -$69,502 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3,075 | -$5,617 | -$2,894 | -$2,050 |
| Net Acquisitions | $0 | $0 | $296,003 | -$144,754 |
| Inv. Purchases | -$532,268 | -$793,907 | -$551,137 | -$389,474 |
| Inv. Sales/Matur. | $700,343 | $682,354 | $258,028 | $144,754 |
| Other Inv. Act. | $0 | $0 | -$296,003 | $144,754 |
| Investing Cash Flow | $165,000 | -$117,170 | -$296,003 | -$246,770 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $12,083 | $353,487 | $277,766 | $447,283 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $47 | $35 | $705 | $260 |
| Financing Cash Flow | $12,130 | $353,522 | $278,471 | $447,543 |
| Forex Effect | -$1,672 | $376 | -$2,484 | -$592 |
| Net Chg. in Cash | -$5,931 | $91,401 | -$118,446 | $130,679 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $148,643 | $57,242 | $175,688 | $45,009 |
| End Cash | $142,712 | $148,643 | $57,242 | $175,688 |
| Free Cash Flow | -$184,464 | -$150,944 | -$101,324 | -$71,552 |